The global pharmaceutical industry will leave the UK unless the country 's National Health Service ( NHS ) receives an extra £ 20bn ( $ 26bn ) , warned a major industry trade group . The Association of the British Pharmaceutical industry ( ABPI ) argued that the increased rationing of treatments is a sign that the NHS is falling in the ranks of the world 's major healthcare systems , causing patients and drug companies to suffer . UK health spending , presently 9.9 % of GDP , should rise to 11.3 % , according to the organisation 's published election campaign results . The demands come as GSK , the UK 's biggest drugs company , announced a £ 2bn rise in first - quarter spending on revenues of £ 7.4bn .
The global pharmaceutical industry will abandon the UK unless the country's National Health Service (NHS) receives an extra £20bn ($26bn), warned a major industry trade group. The Association of the British Pharmaceutical Industry (ABPI) argued that the increased rationing of treatments is a sign that the NHS is falling in the ranks of the world's major health systems, leaving patients and drug companies to suffer. UK health spending, presently 9.9% of GDP, should rise to 11.3%, according to the ABPI's published election campaign requests. The demands come as GSK, the UK's biggest drugs company, announced a £2bn rise in first-quarter profits on revenues of £7.4bn.